In the latest round of vaccine updates, SK Bioscience announced it has signed a licensing deal with American bio firm Novavax to manufacture and distribute the NVX-CoV2373 coronavirus vaccine. While all other vaccine suppliers to Korea have been multinational companies or organizations, under this deal, SK Bioscience will deal directly with Korea authorities for domestic vaccine supplies.

Listen to the full story in this week’s episode. 
Subscribe to the K-Bulletin to listen to Korea’s biggest headline of the day, written by staff reporters of the Korea JoongAng Daily. 

Full Article: https://koreajoongangdaily.joins.com/2021/02/16/business/industry/vaccine-covid-covid19/20210216155900499.html